Search
for

    Sort by

    Community Join

    510-540 / 1000+ results

      community before and after 3 months of meds 20m

      in Progress Pictures  20 upvotes 5 months ago
      A 20-year-old using 1 mg finasteride, 2 ml topical minoxidil, tretinoin, and microneedling for hair loss shows progress after three months, with thicker hair and temple regrowth. No side effects reported, and the user is considering switching to oral minoxidil.

      community 1.5 years minoxidil daily (5%). Fin 1.25 mg daily for 3 months, now switched to MWF schedule. Nizoral every other day, micro needling 1.5mm once a week.

      in Progress Pictures  178 upvotes 3 years ago
      This conversation is about a user's experience with treating hair loss using minoxidil daily, finasteride 1.25 mg every other day and micro needling once a week, as well as their experiences with the side effects of finasteride. Replies to their post shared similar experiences and advice on switching from topical minoxidil to oral.

      community About a year on 0.25mg fin daily

      in Progress Pictures  86 upvotes 2 months ago
      The user has been using 0.25mg finasteride daily for about a year and is considering adding oral minoxidil but is concerned about potential side effects. Most responses suggest sticking with finasteride, possibly increasing the dose, and avoiding oral minoxidil due to its side effects, with some recommending topical minoxidil instead.

      community 2.5 months fin 1mg daily 18 months min 5% twice a day

      in Progress Pictures  146 upvotes 1 year ago
      The user experienced significant hair regrowth and reduced hair loss using finasteride 1mg daily and minoxidil 5% twice a day. Finasteride stopped 90% of hair loss and thickened hair, while minoxidil regrew hair, with minimal side effects reported.

      community Can Pyrilutamide use stopp Minoxidil gains

      in Chat  3 upvotes 2 years ago
      The conversation discusses whether using pyrilutamide would interfere with minoxidil's ability to regrow hair, considering pyrilutamide is seen as a maintenance drug that stops shedding, while minoxidil promotes hair growth but causes initial shedding.

      community Who won’t respond to minoxidil? (Studies)

      in Research/Science  33 upvotes 4 months ago
      Minoxidil's effectiveness varies due to differences in sulfotransferase enzyme levels in the scalp, affecting people with conditions like ASD, liver disease, and androgenic alopecia. Treatments like topical tretinoin, microneedling, and using minoxidil sulfate instead of regular minoxidil can improve results for those with low enzyme levels.

      community Minox 5 Months + Finasterid 3 Months

      in Progress Pictures  384 upvotes 1 year ago
      The user has been using topical minoxidil for 5 months and oral finasteride for 3 months, reporting positive results without side effects. They apply minoxidil twice daily and take 1 mg of finasteride daily.

      community Will Fin+Min save me(6F) ?????

      in Satire  1481 upvotes 11 months ago
      Finasteride and minoxidil are discussed as hair loss treatments, with warnings about minoxidil's toxicity to cats. Suggestions include hair transplants, dutasteride, and humorous alternatives like red light therapy and rosemary oil.

      community discouraged about pyrilutamide

      in Research/Science  11 upvotes 3 years ago
      Discouragement regarding Pyrilutamide, a drug in development for hair loss, and the potential side effects of Finasteride. People discussed anecdotal experiences with Pyrilutamide as well as suggestions to wait out Phase 3 trials before making any conclusions.

      community Waiting to start treatment until Kintor KX-826 Phase 2 data is published?

      in Chat  17 upvotes 4 years ago
      People are waiting for KX-826 (Pyrilutamide) Phase 2 data to decide on hair loss treatments, with some considering finasteride or minoxidil in the meantime. Pyrilutamide is seen as a potentially stronger and safer alternative to finasteride, but concerns about side effects and availability remain.

      community Musely's topical hair solution

      in Finasteride/Dutasteride  6 upvotes 3 years ago
      The conversation discusses a topical hair loss treatment containing 0.1% dutasteride, 6% minoxidil, tretinoin, and ketoconazole. The user is asking for opinions on the effectiveness of this solution.

      community started RU58841 today and am panicing

      in Treatment  8 upvotes 2 years ago
      A user started using RU58841 for hair loss and experienced anxiety and physical discomfort. Other users suggested avoiding the treatment due to similar side effects and recommended alternative treatments like pyri.

      community Kintor long term safety phase 3

      in Research/Science  66 upvotes 1 year ago
      Kintor's phase III trial for pyri (KX-826) showed promising safety and efficacy results, with no drug-related sexual dysfunction reported. Users discussed their experiences with pyri, Minoxidil, Dutasteride, and concerns about the validity of the study results.

      community I am doing an experience with RU58841

      in Treatment 9 months ago
      The conversation discusses a user experimenting with RU58841 for hair regrowth by ingesting it, which others find concerning. There are mentions of potential side effects and comparisons to other treatments like minoxidil, finasteride, and flutamide.

      community I lost the fight against MPB at age 22 despite being on treatments.

      in Finasteride/Dutasteride  72 upvotes 3 years ago
      The user "ajsr8" shared their story of hair loss despite being on treatments. They started using finasteride in 2019 and later tried topical minoxidil, but it didn't seem to work. They also experienced side effects from other treatments. They are considering cutting off their hair and stopping the medications if there is no improvement in three months. Other users suggested trying different treatments and getting a blood test to check for underlying conditions.

      community The story of RU58841/PSK3841

      in Research/Science 1 year ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.